RUMORED BUZZ ON ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS

RUNX1 is really a master transcription element that regulates the expression of various genes essential for hematopoiesis. Studies implied the RUNX1- "Our study disclosed the important position from the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, whic